Skip to content
Tenfell
Awarded contract
Published 28 Sep 2015

UOE/2015/042 Provision of over-encapsulated Sitagliptin (Januvia), Pioglitazone (Actos) and Cangliflozin(Invokana) for double-blind randomised/clin trials.

University of Exeter · South West

Key facts

Contract value
£528,571
Awarded
13 Sep 2015
Contract starts
27 Sep 2015
Contract ends
01 Jul 2019
Procedure
Open procedure
Buyer type
Education

Awarded to

SupplierValue
Tayside Pharmaceuticals£528,571

Description

The University of Exeter is advertising a Call for Competition in seeking a suitable and capable provider ofinvestigational medicinal product for use by its Medical School as part of a diabetes clinical trial. The Universityof Exeter Medical School is undertaking a MRC-funded study aiming to develop a stratified approach in Type2 diabetes that will result in more effective use of glucose lowering therapy. The Trimaster trial, sponsored bythe Royal Devon ανδ Exeter NHS Foundation Trust (RD&E FT) is a randomised double-blind Cross-Over trial ofthree standard diabetes therapies, a DPP4 inhibitor, SGLT2 inhibitor and thiazolidinedione as third line therapyin 600 patients with type 2 diabetes. It aims to directly test potential stratification by comparing a patient's response (in terms of glycaemia, weight change, hypoglycaemia and patient reported outcomes) to these 3glucose-lowering treatments.

Categories (CPV)

Similar open tenders

About University of Exeter

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Contracts Finder archive (Open Contracting) (Open Government Licence v3.0). Always read the original notice before responding.